Cian McCarthy
@CianPMcCarthy
Followers
3K
Following
10K
Media
152
Statuses
1K
Cardiologist @MGHHeartHealth | Former IM Resident @MGHMedicine & CV fellow @MGHCVFELLOWS | Alum: @UCC | Irish ☘️ | Opinions are my own
Boston
Joined December 2017
RT @Heart_SCCT: SCCT is proud to announce the 2025 CTRA winner - Dr. @CianPMcCarthy - for his groundbreaking work on AI in atherosclerotic….
0
2
0
RT @ThijsEijsvogels: Our paper on #cardiac #troponins and #coronary #atherosclerosis in Masters #athletes just got published in @JACCJourna….
0
14
0
Now in @JACCJournals, @ThijsEijsvogels and colleagues find that most exercise induced troponin elevation is not explainable by CAD. @MeaganWasfy and I contextualize these results in accompanying editorial @MGHHeartHealth .
2
23
50
RT @johnwmcevoy: While this content may seem obvious @ first, I humbly believe the idea is more nuanced than first glance and rather profou….
0
4
0
Now in @JACCJournals, @johnwmcevoy and I discuss approaches to defining hypercholesterolemia and hypertension in an era of CVD risk based treatment allocation.
2
8
47
RT @dhrubajyoti1: Last dinner as an Advanced Cardiac Imaging fellow. Grateful for amazing colleagues, inspiring mentors, and a world-class….
0
6
0
RT @JAMACardio: In this Viewpoint, @CianPMcCarthy and colleagues advocate for cardiovascular disease outcome trials for new BP lowering tre….
0
2
0
RT @johnwmcevoy: @NIPCIRELAND @GalwayCMNHS @CiccaroneCenter led by @CianPMcCarthy . Regulatory Approval vs Guideline Endorsement of Nov….
0
1
0
After 20 years of static development, 3 novel BP ⬇️ therapies were FDA approved in 2024. Now in @JAMACardio, led by ⭐️ @UMassChan student Ritika Revoori, we discuss whether BP surrogate endpoint trials are sufficient for endorsement. @johnwmcevoy .
0
6
18
RT @johnwmcevoy: Ever get annoyed working up mildly elevated troponins in older adults who do not have signs of myocardial ischemia? Turns….
0
28
0
RT @chapdoc1: The TARGET-Type 2 pilot RCT demonstrates it is feasible to randomise patients with Type 2 MI to CTCA and echocardiography gui….
0
8
0
RT @MananPareekMD: Our new meta-analysis in @JACCJournals @hmkyale led by @anoopshah17: Cardiac Troponins and CV Risk Prediction!. Measurem….
0
6
0
In this weeks edition of @JACCJournals, Dr. Shah and colleagues explore the use of hs-cTn in CVD risk prediction for primary prevention. Drs. Januzzi, @johnwmcevoy, and I discuss the implication of their findings.
1
9
36
RT @JAMAInternalMed: 7% of all patients in US emergency departments underwent cardiac biomarker testing, with variability in testing practi….
0
3
0
RT @jhamawra95: Read our article "Lipoprotein(a) – From Biomarker to Therapy: A Review for the Clinician." Our review covers its clinical s….
0
2
0
End/ Low dose colchine may be reasonable (Class IIb) for ACS patients
0
1
12
13/ Home based cardiac rehab (CR) is a reasonable alternative to in-person CR. Recommended to refer to CR before discharge.
1
0
11